P53 tumour suppressor gene and RAS oncogenes: Molecular analysis in the chronic and leukaemic phases of essential thrombocythaemia

Antonino Neri, Nicola Stefano Fracchiolla, Franca Radaelli, Alketa Boletini, Sonia Ribera, Chiara Migliorini, Dino Trecca, Anna Teresa Maiolo

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

A panel of 51 cases of essential thrombocythaemia (ET), in chronic or leukaemic phase, was investigated for p53 gene and RAS oncogenes mutations by PCR-SSCP-direct sequencing. No RAS oncogenes mutations were detected, but p53 mutations were identified in three cases: 1/27 cases (~4%) in chronic phase not undergoing chemotherapy, 1/19 cases (~5%) in chronic phase undergoing chemotherapy, and 1/5 cases (20%) which had progressed to leukaemia. Our results suggest that: (1) p53 gene mutations occur sporadically in the chronic phase of ET, independent of chemotherapy, and may contribute to the progression to the leukaemic phase in a limited number of ET patients; (2) the RAS genes family does not seem to be involved in the pathogenesis of ET, unlike other bcr/abl negative chronic myeloproliferative diseases (CMPDs).

Original languageEnglish
Pages (from-to)670-673
Number of pages4
JournalBritish Journal of Haematology
Volume93
Issue number3
Publication statusPublished - 1996

Fingerprint

Essential Thrombocythemia
Tumor Suppressor Genes
Oncogenes
Mutation
p53 Genes
Drug Therapy
Single-Stranded Conformational Polymorphism
Leukemia
Chronic Disease
Polymerase Chain Reaction
Genes

Keywords

  • Essential thrombocythaemia
  • Leukaemic phase
  • p53
  • RAS

ASJC Scopus subject areas

  • Hematology

Cite this

P53 tumour suppressor gene and RAS oncogenes : Molecular analysis in the chronic and leukaemic phases of essential thrombocythaemia. / Neri, Antonino; Fracchiolla, Nicola Stefano; Radaelli, Franca; Boletini, Alketa; Ribera, Sonia; Migliorini, Chiara; Trecca, Dino; Maiolo, Anna Teresa.

In: British Journal of Haematology, Vol. 93, No. 3, 1996, p. 670-673.

Research output: Contribution to journalArticle

@article{d4bf2a8c6cca49d091ecfd94b40a59cb,
title = "P53 tumour suppressor gene and RAS oncogenes: Molecular analysis in the chronic and leukaemic phases of essential thrombocythaemia",
abstract = "A panel of 51 cases of essential thrombocythaemia (ET), in chronic or leukaemic phase, was investigated for p53 gene and RAS oncogenes mutations by PCR-SSCP-direct sequencing. No RAS oncogenes mutations were detected, but p53 mutations were identified in three cases: 1/27 cases (~4{\%}) in chronic phase not undergoing chemotherapy, 1/19 cases (~5{\%}) in chronic phase undergoing chemotherapy, and 1/5 cases (20{\%}) which had progressed to leukaemia. Our results suggest that: (1) p53 gene mutations occur sporadically in the chronic phase of ET, independent of chemotherapy, and may contribute to the progression to the leukaemic phase in a limited number of ET patients; (2) the RAS genes family does not seem to be involved in the pathogenesis of ET, unlike other bcr/abl negative chronic myeloproliferative diseases (CMPDs).",
keywords = "Essential thrombocythaemia, Leukaemic phase, p53, RAS",
author = "Antonino Neri and Fracchiolla, {Nicola Stefano} and Franca Radaelli and Alketa Boletini and Sonia Ribera and Chiara Migliorini and Dino Trecca and Maiolo, {Anna Teresa}",
year = "1996",
language = "English",
volume = "93",
pages = "670--673",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley & Sons, Ltd (10.1111)",
number = "3",

}

TY - JOUR

T1 - P53 tumour suppressor gene and RAS oncogenes

T2 - Molecular analysis in the chronic and leukaemic phases of essential thrombocythaemia

AU - Neri, Antonino

AU - Fracchiolla, Nicola Stefano

AU - Radaelli, Franca

AU - Boletini, Alketa

AU - Ribera, Sonia

AU - Migliorini, Chiara

AU - Trecca, Dino

AU - Maiolo, Anna Teresa

PY - 1996

Y1 - 1996

N2 - A panel of 51 cases of essential thrombocythaemia (ET), in chronic or leukaemic phase, was investigated for p53 gene and RAS oncogenes mutations by PCR-SSCP-direct sequencing. No RAS oncogenes mutations were detected, but p53 mutations were identified in three cases: 1/27 cases (~4%) in chronic phase not undergoing chemotherapy, 1/19 cases (~5%) in chronic phase undergoing chemotherapy, and 1/5 cases (20%) which had progressed to leukaemia. Our results suggest that: (1) p53 gene mutations occur sporadically in the chronic phase of ET, independent of chemotherapy, and may contribute to the progression to the leukaemic phase in a limited number of ET patients; (2) the RAS genes family does not seem to be involved in the pathogenesis of ET, unlike other bcr/abl negative chronic myeloproliferative diseases (CMPDs).

AB - A panel of 51 cases of essential thrombocythaemia (ET), in chronic or leukaemic phase, was investigated for p53 gene and RAS oncogenes mutations by PCR-SSCP-direct sequencing. No RAS oncogenes mutations were detected, but p53 mutations were identified in three cases: 1/27 cases (~4%) in chronic phase not undergoing chemotherapy, 1/19 cases (~5%) in chronic phase undergoing chemotherapy, and 1/5 cases (20%) which had progressed to leukaemia. Our results suggest that: (1) p53 gene mutations occur sporadically in the chronic phase of ET, independent of chemotherapy, and may contribute to the progression to the leukaemic phase in a limited number of ET patients; (2) the RAS genes family does not seem to be involved in the pathogenesis of ET, unlike other bcr/abl negative chronic myeloproliferative diseases (CMPDs).

KW - Essential thrombocythaemia

KW - Leukaemic phase

KW - p53

KW - RAS

UR - http://www.scopus.com/inward/record.url?scp=0029938573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029938573&partnerID=8YFLogxK

M3 - Article

C2 - 8652390

AN - SCOPUS:0029938573

VL - 93

SP - 670

EP - 673

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 3

ER -